Skip to content
Home/Companies/Biotech/Aeovian Pharmaceuticals
AP

Aeovian Pharmaceuticals

Biotech·United States·Active·7yr hold

Aeovian Pharmaceuticals is a biotech company, headquartered in United States.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Aeovian Pharmaceuticals?

Aeovian Pharmaceuticals is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund I (2018 vintage), since 2019.

Hand-verified · updated 2026-07-03

Apollo Health Ventures
Investor
Apollo Health Ventures
Apollo Health Ventures Fund I · 2018 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Apollo Health Ventures Fund I

Other portfolio companies in the same fund.

Refoxy Pharmaceuticals
Active
BiotechGermany· 2020
Samsara Therapeutics
Active
BiotechUnited Kingdom· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings